US Patent 10154990 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Boehringer Ingelheim GmbH

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

Contact Supplier

dmfs-not-supported-m-2025-06-30

granules-india-limited-m-2025-07-07

Contact Supplier

Allsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

Contact Supplier

jdmfs-not-supported-m-2025-06-30

Boehringer Ingelheim GmbH

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 1258 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
1258 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

148 All APIs, 86 USDMF, 44 CEP/COS, 13 JDMF, 19 KDMF, 29 NDC API, 13 VMF, 2 Listed APIs

148 All APIs
86 USDMF
44 CEP/COS
13 JDMF
19 KDMF
29 NDC API
13 VMF
2 Listed APIs

DEVELOPMENTS

112 Drugs in Development

112 Drugs in Development

FINISHED DOSAGE FORMULATIONS

1053 FDF Dossiers, 288 FDA Orange Book, 372 Europe, 123 Canada, 116 Australia, 152 South Africa, 2 Listed Dossiers

1053 FDF Dossiers
288 FDA Orange Book
372 Europe
123 Canada
116 Australia
152 South Africa
2 Listed Dossiers

INSPECTIONS & REGISTRATIONS

87 FDA, 33 EDQM, 3 GDUFA

87 FDA
33 EDQM
3 GDUFA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2BOEHRINGER INGELHEIM

filter Patent Number Reset all filters

2 All

01 210154990

API Patent Reset all filters

2 All

01 2Blank

FDF Patent Reset all filters

2 All

01 2Blank

filter Expiration Date Reset all filters

2 All

01 22026-01-08

01

BOEHRINGER INGELHEIM

NINTEDANIB ESYLATE

IFT FIRST

Not Confirmed

BOEHRINGER INGELHEIM

IFT FIRST

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-01-08

NINTEDANIB ESYLATE

US Patent Number : 10154990

Drug Substance Claim :

Drug Product Claim :

Application Number : 205832

Patent Use Code : U-2620

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BOEHRINGER INGELHEIM

NINTEDANIB ESYLATE

IFT FIRST

Not Confirmed

BOEHRINGER INGELHEIM

IFT FIRST

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-01-08

NINTEDANIB ESYLATE

US Patent Number : 10154990

Drug Substance Claim :

Drug Product Claim :

Application Number : 205832

Patent Use Code : U-2620

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!